| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |